Latest Intelligence on Genomics, Proteomics and Pharmacogenomics

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | » »|

Type Product title / description Pub Price
Expert View
Expert View

Will biotech companies take control in licensing deals?

Published By Datamonitor
12 Oct 2001
CommentWire
CommentWire

Virco: looking into the future of AIDS therapy

Published By Datamonitor
17 Jul 2001
CommentWire
CommentWire

Vical: modified Leuvectin trials could do better

Published By Datamonitor
23 Apr 2001
CommentWire
CommentWire

Vaccines: newly discovered immunity gene holds huge potential

A newly identified SAP gene promises to increase the efficacy of a range of vaccines. A key decision will now be whether to license the technology for use by vaccines manufacturers or to develop a gene vaccine supplement. Either way, however, the discovery promises to attract keen attention amongst vaccine makers.<BR />

Published By Datamonitor
16 Jan 2003
CommentWire
CommentWire

UK biotech: new heads for the biggest headaches

The UK's biotech leaders - Celltech, CAT, OGS and British Biotech - have all appointed or are about to appoint new CEOs. Not surprising, given the companies' recent poor results both in financial and drug development terms. The changes should signal a shift towards efficient drug development, and a new focus on profitable business development.

Published By Datamonitor
21 Nov 2002
Expert View
Expert View

Tuberculosis strikes back

During the 1990s tuberculosis was responsible for 30 million deaths. Yet no new classes of tuberculosis products have appeared since 1966 and the bacterium is building a resistance to what drugs there are. The fear is someday soon the world could fall victim to a tuberculosis epidemic. While this has prompted renewed interest in tuberculosis, is it in companies' interests to invest in the market?

Published By Datamonitor
18 Jan 2002
Expert View
Expert View

The impact of IT on next-generation DNA sequencing

The mystery behind why some have a genetic disposition to a certain disease, or why a medicine works for some and not for others, might be revealed sooner than many had anticipated. In the past couple of months, several significant breakthroughs in DNA sequencing technology have been made, giving hope to the researchers that the coveted $1,000 genome is just around the corner.

Published By Datamonitor
21 Apr 2008
Expert View
Expert View

Standing on the shoulders of genomics giants

Published By Datamonitor
22 Jan 2001
Expert View
Expert View

SNP, SNP, cut the tickertape

Published By Datamonitor
18 May 2001
CommentWire
CommentWire

Skin cancer: gene discovery raises cure hopes

Scientists have discovered a faulty gene that is present in 70% of skin tumors. The research has raised hopes that new therapies will soon become available. However, the complexity of tumor genetics and the drug development process mean that it will be some time before patients and pharma companies benefit from the discovery.

Published By Datamonitor
10 Jun 2002

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | » »|

No help is available.